查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566894

退伍軍人菌檢測套組市場：按類型、最終用戶分類：2024-2033 年全球機會分析與產業預測

Legionella Testing Kits Market By Type , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

退伍軍人菌檢測套組市場

2023 年退伍軍人菌檢測套組市值為 3.24 億美元，預計 2024 年至 2033 年複合年成長率為 7.7%，到 2033 年將達到 6.845 億美元。

退伍軍人菌檢測套組是快速 DIY 測試儀，可檢測退伍軍人菌。該套件主要用於療養院、醫院、餐旅服務業、游泳池、噴泉和冷卻塔等空間。使用各種生物分子過程進行測試，包括培養、聚合酵素鏈鎖反應和免疫測定。套件的主要特點包括交付快、精度高、易於使用。

對預防水傳播感染疾病的認知不斷提高是退伍軍人菌檢測套組市場的主要促進因素。日益嚴格的公共法規正在推動商業和公共設施中採用檢測套組。此外，技術進步正在提高檢測套組的有效性和可靠性，支持市場開拓。最近的趨勢包括快速交付測試結果以及與數位解決方案的整合。為了促進測試結果的無縫分析和報告，製造商正在設計可以與數位資料管理系統整合的套件。這種整合可幫助您追蹤水質和安全模式並做出有效的決策。

然而，高精度和高精度的高級版本套件的成本仍然相當高，限制了小型組織的購買。此外，樣本採集和套件處理是複雜的過程，需要培訓和實踐。套件的輕微污染會影響其可靠性並阻礙市場成長。相反，政府在公共場所和建築物中定期進行水質檢測的舉措正在為市場創造利潤豐厚的機會。例如，在美國，將於 2024 年 1 月對多棟聯邦政府大樓進行水質檢測，以確保在大樓內參觀或工作的人員的健康。

按部門審查

退伍軍人菌檢測套組市場按類型、最終用戶和地區細分。按類型分類，市場分為培養基、尿液抗原測試、聚合酵素鏈鎖反應、血清學和直接螢光抗體測試。依最終使用者分為醫院/診所、臨床實驗室等。從區域來看，我們對北美、歐洲、亞太地區和拉丁美洲地區進行了分析。

主要發現

按類型分類，聚合酵素鏈鎖反應領域在 2023 年佔據最大佔有率。

從最終用戶來看，醫院和診所細分市場將在 2023 年獲得較高的市場佔有率。

按地區分類，北美地區 2023 年收益最高。

可以使用此報告進行客製化（需要額外費用和時間表）

  • 根據客戶興趣加入公司簡介

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章退伍軍人菌檢測套組市場：按類型

  • 市場概況
  • 培養基
  • 尿液抗原檢測
  • 聚合酵素鏈鎖反應
  • 血清檢測
  • 直接螢光抗體測試

第5章退伍軍人菌檢測套組市場：依最終用戶分類

  • 市場概況
  • 醫院和診所
  • 臨床實驗室
  • 其他

第6章退伍軍人菌檢測套組市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國退伍軍人菌檢測套組市場
    • 加拿大軍團退伍軍人菌檢測套組市場
    • 墨西哥軍團退伍軍人菌檢測套組市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國退伍軍人菌檢測套組市場
    • 德國軍團退伍軍人菌檢測套組市場
    • 義大利退伍軍人菌檢測套組市場
    • 西班牙退伍軍人菌檢測套組市場
    • 英國退伍軍人菌檢測套組市場
    • 其他歐洲國家退伍軍人菌檢測套組市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國退伍軍人菌檢測套組市場
    • 日本退伍軍人菌檢測套組市場
    • 印度退伍軍人菌檢測套組市場
    • 韓國退伍軍人菌檢測套組市場
    • 澳洲軍團退伍軍人菌檢測套組市場
    • 其他亞太軍團退伍軍人菌檢測套組市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西軍團退伍軍人菌檢測套組市場
    • 南非軍團退伍軍人菌檢測套組市場
    • 沙烏地阿拉伯軍團退伍軍人菌檢測套組市場
    • 其他拉丁美洲/中東/非洲軍團退伍軍人菌檢測套組市場

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第8章 公司簡介

  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific
  • Merck Group KGaA
  • Pall Corporation
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories
  • Hygiena
  • Veolia Water Technologies
  • Pro-Lab Diagnostics
  • Phigenics, LLC
簡介目錄
Product Code: A264537

Legionella Testing Kits Market

The legionella testing kits market was valued at $324.0 million in 2023 and is projected to reach $684.5 million by 2033, growing at a CAGR of 7.7% from 2024 to 2033.

A legionella testing kit is a rapid do-it-yourself tester which enables detection of the bacteria Legionella. This kit is essentially used in spaces such as care homes & hospitals, hospitality, pools & fountains, and cooling towers. The testing is performed using diverse biomolecular processes such as culture method, polymerase chain reaction technique, or immunological assay. The key attributes of the kit include short turnaround time, high precision, and ease of usage.

Increase in awareness about the prevention of water borne diseases is a key driver of the legionella testing kits market. Commercial and public buildings have strengthened their regulations regarding public safety, boosting the adoption of testing kits. In addition, advancements in technology have enhanced the efficacy and reliability of the kits, thereby augmenting the development of the market. In recent times, quick delivery of results and integration of the kits with digital solutions are the prominent trends acquiring traction. To facilitate seamless analysis and reporting of test results, manufacturers are designing kits with the ability to be assimilated with digital data management systems. This integration assists in tracking the patterns of water quality & safety and making effective decisions.

However, the cost of advanced version of kits with high precision and accuracy remains significantly high, restricting small organizations from purchasing them. Furthermore, the collection and handling of the sample & kit is a complex process which requires training & practice. Slight contamination of the kit impacts its reliability, thereby hampering the growth of the market. Contrarily, efforts by governments to conduct periodic water testing in public places and buildings are presenting lucrative opportunities for the market. For instance, the U.S. General Service Administration conducted water testing across several federal buildings in January 2024 to ensure the wellness of individuals visiting and working in the buildings.

Segment Review

The legionella testing kits market is segmented into type, end user, and region. On the basis of type, the market is divided into culture media, urine antigen testing, polymerase chain reaction, serology, and direct fluorescent antibody test. Depending on end user, it is classified into hospitals & clinics, clinical laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the polymerase chain reaction segment accounted for the largest share in 2023.

Depending on end user, the hospitals & clinics segment acquired a high stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global legionella testing kits market include IDEXX Laboratories, Inc., Thermo Fisher Scientific, Merck Group KGaA, Pall Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Hygiena, Veolia Water Technologies, Pro-Lab Diagnostics, and phigenics, llc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Type

  • Culture Media
  • Urine Antigen Testing
  • Polymerase Chain Reaction
  • Serology
  • Direct Fluorescent Antibody Test

By End User

  • Hospitals and Clinics
  • Clinical Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck Group KGaA
    • Pall Corporation
    • Bio-Rad Laboratories, Inc.
    • Abbott Laboratories
    • Hygiena
    • Veolia Water Technologies
    • Pro-Lab Diagnostics
    • Phigenics, LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: LEGIONELLA TESTING KITS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Culture Media
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Urine Antigen Testing
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Polymerase Chain Reaction
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Serology
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Direct Fluorescent Antibody Test
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: LEGIONELLA TESTING KITS MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Clinical Laboratories
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: LEGIONELLA TESTING KITS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Legionella Testing Kits Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Legionella Testing Kits Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Legionella Testing Kits Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Legionella Testing Kits Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. Germany Legionella Testing Kits Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. Italy Legionella Testing Kits Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Spain Legionella Testing Kits Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. UK Legionella Testing Kits Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Legionella Testing Kits Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Legionella Testing Kits Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. Japan Legionella Testing Kits Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Legionella Testing Kits Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. South Korea Legionella Testing Kits Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. Australia Legionella Testing Kits Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Legionella Testing Kits Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Legionella Testing Kits Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. South Africa Legionella Testing Kits Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. Saudi Arabia Legionella Testing Kits Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Legionella Testing Kits Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. IDEXX Laboratories, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Thermo Fisher Scientific
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Merck Group KGaA
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Pall Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Bio-Rad Laboratories, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Abbott Laboratories
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Hygiena
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Veolia Water Technologies
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Pro-Lab Diagnostics
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Phigenics, LLC
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments